BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31701672)

  • 1. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
    Bao G; Huang J; Pan W; Li X; Zhou T
    Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression.
    Yan L; Li K; Feng Z; Zhang Y; Han R; Ma J; Zhang J; Wu X; Liu H; Jiang Y; Zhang Y; Zhu Y
    Mol Carcinog; 2020 Oct; 59(10):1199-1208. PubMed ID: 32808708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C.
    Pan W; Chen KJ; Huang YC
    Anticancer Drugs; 2022 Oct; 33(9):913-922. PubMed ID: 36136991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF2BP3 Worsens Lung Cancer through Modifying Long Non-coding RNA CERS6-AS1/microRNA-1202 Axis.
    Yan A; Song X; Liu B; Zhu K
    Curr Med Chem; 2023; 30(7):878-891. PubMed ID: 35702784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CERS6-AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR-195-5p/WIPI2 axis.
    Gao KF; Zhao YF; Liao WJ; Xu GL; Zhang JD
    Kaohsiung J Med Sci; 2022 Jun; 38(6):542-553. PubMed ID: 35199935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CERS6-AS1 Is a Tumor Promoter in Cervical Cancer by Sponging miR-195-5p.
    Xiong S; Song H
    Ann Clin Lab Sci; 2023 Jan; 53(1):30-41. PubMed ID: 36889776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis.
    Yun Z; Meng F; Li S; Zhang P
    Aging (Albany NY); 2021 Feb; 13(4):6041-6054. PubMed ID: 33581689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CERS6-AS1 contributes to the malignant phenotypes of colorectal cancer cells by interacting with miR-15b-5p to regulate SPTBN2.
    Zhao SY; Wang Z; Wu XB; Zhang S; Chen Q; Wang DD; Tan QF
    Kaohsiung J Med Sci; 2022 May; 38(5):403-414. PubMed ID: 35146902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2.
    Yan K; Hu C; Liu C; Chu G; Wang X; Ma S; Li L
    Histol Histopathol; 2023 Jul; 38(7):823-835. PubMed ID: 36444938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
    Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
    Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
    Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
    Luo N; Zhang K; Li X; Hu Y
    J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110/HDAC2/PLIN1 axis.
    Lu C; Wang X; Zhao X; Xin Y; Liu C
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32110804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lncRNA CERS6-AS1 in cancer and its molecular mechanisms: A systematic review and meta-analysis.
    Rastad H; Samimisedeh P; Alan MS; Afshar EJ; Ghalami J; Hashemnejad M; Alan MS
    Pathol Res Pract; 2023 Jan; 241():154245. PubMed ID: 36580796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CERS6 antisense RNA 1 promotes colon cancer via upregulating mitochondrial calcium uniporter.
    Yu J; Chen X; Li J; Wang F
    Eur J Clin Invest; 2023 May; 53(5):e13951. PubMed ID: 36628448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYC-activated CERS6-AS1 sponges miR-6838-5p and regulates the expression of RUBCNL in colorectal cancer.
    Chen D; You H; Xu X; Liu D; Shen M; Pan Y; Liu Z; Zhang L; Wang H
    Cell Mol Biol (Noisy-le-grand); 2022 Dec; 68(12):42-48. PubMed ID: 37130182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
    Yang J; Wu W; Wu M; Ding J
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
    Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
    Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.